| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6193970 |
Controlled release of pharmaceutically active substances for immunotherapy |
Feb. 27, 2001 |
| 6194376 |
Method for modulating inflammatory response comprising administering morphogen |
Feb. 27, 2001 |
| 6191104 |
Methods of treating graft rejection with the IL-17 receptor |
Feb. 20, 2001 |
| 6184206 |
Integrin ligand dissociators |
Feb. 6, 2001 |
| 6180599 |
Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease |
Jan. 30, 2001 |
| 6177059 |
GPIb-lipid complex and uses thereof |
Jan. 23, 2001 |
| 6177085 |
Generation of immune response using immunogenic conjugate of molecules |
Jan. 23, 2001 |
| 6177404 |
Conjugates useful in the treatment of benign prostatic hyperplasia |
Jan. 23, 2001 |
| 6174529 |
Oral therapy for the treatment of allergies and method of manufacture |
Jan. 16, 2001 |
| 6172040 |
Immobilized lactoferrin antimicrobial agents and the use thereof |
Jan. 9, 2001 |
| 6172107 |
Entric-coated pharmaceutical compositions |
Jan. 9, 2001 |
| 6171584 |
Method of treatment with growth/differentiation factors of the TGF-.beta. family |
Jan. 9, 2001 |
| 6171614 |
Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
Jan. 9, 2001 |
| 6168785 |
Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
Jan. 2, 2001 |
| 6169068 |
Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives |
Jan. 2, 2001 |
| 6165459 |
Methods for suppressing myeloid cells with chemokines |
Dec. 26, 2000 |
| 6162426 |
Use of G-CSF to enhance the immune system in neonates |
Dec. 19, 2000 |
| 6162427 |
Combination of G-CSF with a chemotherapeutic agent for stem cell mobilization |
Dec. 19, 2000 |
| 6162432 |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
Dec. 19, 2000 |
| 6162787 |
Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
Dec. 19, 2000 |
| 6159174 |
Method of using lectins for therapy of diseases transmittable by sexual contact |
Dec. 12, 2000 |
| 6159460 |
Method for treating interleukin-1 mediated diseases |
Dec. 12, 2000 |
| 6159463 |
Lymphocyte chemoattractant factor |
Dec. 12, 2000 |
| 6159711 |
DNA encoding rantes peptide fragments and methods of treatment with the fragments |
Dec. 12, 2000 |
| 6156300 |
Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments thereof |
Dec. 5, 2000 |
| 6156301 |
Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors |
Dec. 5, 2000 |
| 6153182 |
Lymphotactin as an adjuvant |
Nov. 28, 2000 |
| 6153195 |
Method of delivering drugs to cells specific for an HL-60 lectin |
Nov. 28, 2000 |
| 6153200 |
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
Nov. 28, 2000 |
| 6150326 |
Means for treating autoimmune diseases and method for the treatment thereof |
Nov. 21, 2000 |
| 6150327 |
Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
Nov. 21, 2000 |
| 6150331 |
Human growth hormone-containing aqueous pharmaceutical composition |
Nov. 21, 2000 |
| 6150461 |
Carriers targettable to organ |
Nov. 21, 2000 |
| 6146658 |
Prodrugs, their preparation and use as pharmaceuticals |
Nov. 14, 2000 |
| 6143331 |
Pharmaceutical composition which is stable during storage and contains a thymus extract |
Nov. 7, 2000 |
| 6138680 |
Method for destroying retinal pigment epithelial cells |
Oct. 31, 2000 |
| 6133230 |
Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and TGF-.beta., optionally in combination with IGF-1 |
Oct. 17, 2000 |
| 6126933 |
Methods of treating inflammatory bowel diseases by administering IL-11 |
Oct. 3, 2000 |
| 6126945 |
Tumor killing effects of enterotoxins, superantigens, and related compounds |
Oct. 3, 2000 |
| 6124257 |
Method of treatment |
Sep. 26, 2000 |
| 6124260 |
Inhibition of smooth muscle cell migration by Tenascin-C peptides |
Sep. 26, 2000 |
| 6120760 |
Growth/differentiation factors of the TGF-.beta. family |
Sep. 19, 2000 |
| 6121231 |
Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
Sep. 19, 2000 |
| 6121233 |
Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
Sep. 19, 2000 |
| 6117837 |
Inhibiting proinflammatory cytokine production |
Sep. 12, 2000 |
| 6114310 |
Efflux pump inhibitors |
Sep. 5, 2000 |
| 6110890 |
Treatment of Dutch elm disease |
Aug. 29, 2000 |
| 6110891 |
Lectin compositions and uses thereof |
Aug. 29, 2000 |
| 6106823 |
Treatment of neoplastic disease with interleukin-10 |
Aug. 22, 2000 |
| 6106828 |
Conjugation of polypeptides |
Aug. 22, 2000 |
|
|
|
